T1	location 113 119	Taiwan
T2	intervention 74 109	Self-Management Support mHealth App
T3	duration 285 294	2017-2018
T4	eligibility 739 886	women with stage 0 to III breast cancer, who were recruited from social networking sites or referred by their oncologists or oncology case managers
T5	control 930 944	control groups
T6	control 1033 1043	usual care
T7	No-of-participants 1813 1816	112
T8	intervention-participants 1896 1898	53
T9	control-participants 1920 1922	59
T10	No-of-participants 1966 1969	100
T11	outcome-Measure 1063 1260	-the European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life Questionnaire Core 30 (QLQ-C30) and the EORTC Breast Cancer-Specific Quality-of-Life Questionnaire (QLQ-BR23)
T12	outcome 2201 2230	mean total QoL summary scores
T13	outcome 2240 2247	QLQ-C30
T14	outcome 2280 2288	QLQ-BR23
